438554-44-0 Usage
General Description
5-nitro-2-(trifluoroMethyl)pyridin-4-ol is a chemical compound with the molecular formula C6H4F3N2O3. It consists of a pyridine ring with a nitro group at the 5-position and a trifluoromethyl group at the 2-position, as well as a hydroxyl group at the 4-position. 5-nitro-2-(trifluoroMethyl)pyridin-4-ol is often used in the synthesis of pharmaceuticals and agrochemicals due to its unique structure and properties. It has also been studied for its potential biological activities, including its antibacterial and antitumor properties. Additionally, it is used as a building block in organic chemistry and can be modified to create new derivative compounds with specific functions and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 438554-44-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,5,5 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 438554-44:
(8*4)+(7*3)+(6*8)+(5*5)+(4*5)+(3*4)+(2*4)+(1*4)=170
170 % 10 = 0
So 438554-44-0 is a valid CAS Registry Number.
438554-44-0Relevant articles and documents
FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF
-
Paragraph 0304-0306, (2022/02/09)
The present disclosure generally relates to improved synthesis of fused bicyclic Raf inhibitors of formula (I), (I-A), (I-B), (II), or (III), or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof. The disclosure also relates to method o
PYRIDO PYRIMIDINONES, DIHYDRO PYRIMIDO PYRIMIDINONES AND PTERIDINONES USEFUL AS RAF KINASE INHIBITORS
-
Page/Page column 108, (2010/11/08)
The present invention provides compounds having the formula: (I) wherein A-B together represents one of the following structures; (II), (III), (IV) and n, R1, R2, R3, R4, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., RAF), and thus are useful, for example, for the treatment of RAF mediated diseases.
